During the past decade, Department of Dermatology, Ruhr University Bochum conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of Dermatology, Ruhr University Bochum" are "Atopic Dermatitis" (2 trials), "HIV Infections" (2 trials), "Papillomavirus Infections" (2 trials), "Anal Intraepithelial Neoplasia" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Department of Dermatology, Ruhr University Bochum" in a lesser frequency.

Most popular intervention types in "Department of Dermatology, Ruhr University Bochum" are "Drug" (2 trials), "Procedure" (2 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "UVA1 phototherapy" (2 trials), "Bath-PUVA" (1 trials), "Cortisone" (1 trials), "NB-UVB" (1 trials) and "NB-UVB phototherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Dermatology, Ruhr University Bochum" are 4 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Department of Dermatology, Ruhr University Bochum". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Department of Dermatology, Ruhr University Bochum, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Dermatology, Ruhr University Bochum, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".